ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 131 filers reported holding ALBANY MOLECULAR RESH INC in Q2 2015. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $55,931,000 | +84.8% | 2,577,470 | +19.5% | 3.61% | +68.8% |
| Q1 2017 | $30,268,000 | +17.0% | 2,157,370 | +56.4% | 2.14% | +6.6% |
| Q4 2016 | $25,880,000 | +14.2% | 1,379,517 | +0.5% | 2.00% | +15.1% |
| Q3 2016 | $22,660,000 | -3.4% | 1,372,510 | +16.2% | 1.74% | -16.3% |
| Q4 2015 | $23,448,000 | +32.3% | 1,181,270 | +16.1% | 2.08% | +13.2% |
| Q3 2015 | $17,725,000 | -11.7% | 1,017,480 | +2.4% | 1.84% | -3.9% |
| Q2 2015 | $20,084,000 | +14.4% | 993,280 | -0.4% | 1.91% | +10.8% |
| Q1 2015 | $17,552,000 | +5.8% | 997,290 | -2.1% | 1.73% | -4.1% |
| Q4 2014 | $16,588,000 | -10.5% | 1,018,920 | +10.6% | 1.80% | -13.6% |
| Q2 2014 | $18,541,000 | +10.9% | 921,500 | +2.5% | 2.08% | +5.7% |
| Q1 2014 | $16,721,000 | +75.3% | 899,450 | -4.9% | 1.97% | +66.8% |
| Q4 2013 | $9,537,000 | -4.7% | 946,150 | +21.9% | 1.18% | -12.0% |
| Q3 2013 | $10,003,000 | – | 776,000 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 567,400 | $11,473,000 | 12.05% |
| Permian Investment Partners, LP | 1,875,650 | $37,926,000 | 7.67% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 1,490,174 | $30,131,000 | 2.57% |
| AMERICAN CAPITAL MANAGEMENT INC | 993,280 | $20,084,000 | 1.91% |
| Netols Asset Management, Inc. | 387,471 | $7,835,000 | 1.54% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,158,759 | $23,430,000 | 1.35% |
| Evercore Wealth Management, LLC | 1,233,880 | $24,948,000 | 1.13% |
| Visium Asset Management, LP | 3,200,000 | $64,704,000 | 0.92% |
| Granite Investment Partners, LLC | 303,787 | $6,143,000 | 0.57% |
| FRANKLIN STREET ADVISORS INC /NC | 144,125 | $2,914,000 | 0.52% |